Streptococcus Group B Antigen Detection Test
Understanding Group B Streptococcus Screening
The Streptococcus Group B Antigen Detection Test represents a critical advancement in infectious disease diagnostics, specifically designed to identify Group B Streptococcus (GBS) antigens in patient samples. Group B Streptococcus is a significant bacterial pathogen that can cause severe infections in vulnerable populations, particularly newborns, pregnant women, elderly individuals, and those with compromised immune systems.
This sophisticated diagnostic tool utilizes latex agglutination methodology to detect specific bacterial antigens, providing healthcare providers with rapid, reliable results to guide appropriate treatment decisions. The test’s importance extends beyond simple detection—it serves as a frontline defense against potentially life-threatening infections that can lead to sepsis, meningitis, pneumonia, and other serious complications if left untreated.
What the Test Detects and Measures
The Streptococcus Group B Antigen Detection Test specifically identifies the presence of Group B Streptococcus bacterial antigens in various body fluids. This advanced diagnostic approach targets:
- Group B Streptococcus surface antigens – Specific protein markers unique to this bacterial strain
- Bacterial presence in multiple sample types – Including serum, cerebrospinal fluid (CSF), and urine
- Active infection markers – Detecting current bacterial colonization or infection
- Antigen concentration levels – Providing semi-quantitative assessment of bacterial load
The test employs latex agglutination technology, where latex particles coated with specific antibodies bind to Group B Streptococcus antigens, creating visible clumping that indicates a positive result. This method offers excellent sensitivity and specificity for rapid detection.
Who Should Consider This Test
Several patient populations benefit from Streptococcus Group B Antigen Detection testing:
Pregnant Women
- Routine screening between 35-37 weeks of pregnancy
- Women with previous GBS-positive infants
- Pregnant women experiencing urinary tract infections
- Those with fever during labor
Newborns and Infants
- Infants showing signs of early-onset GBS disease (within first week of life)
- Babies with respiratory distress, fever, or feeding difficulties
- Newborns born to GBS-positive mothers
- Infants with suspected sepsis or meningitis
Adults and Elderly Patients
- Individuals with compromised immune systems
- Patients with chronic medical conditions (diabetes, cancer, heart disease)
- Those experiencing recurrent urinary tract infections
- Patients with symptoms of bacteremia or soft tissue infections
Key Benefits of Streptococcus Group B Testing
Choosing the Streptococcus Group B Antigen Detection Test offers numerous advantages for patients and healthcare providers:
- Rapid Results – Same-day turnaround enables quick treatment decisions
- High Accuracy – Latex agglutination method provides reliable detection
- Multiple Sample Options – Testing available for serum, CSF, and urine samples
- No Special Preparation – Convenient testing with minimal patient burden
- Cost-Effective Screening – Affordable pricing at only $26 makes testing accessible
- Early Detection – Identifies infections before serious complications develop
- Treatment Guidance – Results help determine appropriate antibiotic therapy
- Prevention of Transmission – Particularly important for preventing neonatal infections
Understanding Your Test Results
Interpreting your Streptococcus Group B Antigen Detection Test results is straightforward with proper medical guidance:
Positive Result
A positive test indicates the presence of Group B Streptococcus antigens in your sample. This typically means:
- Active Group B Streptococcus colonization or infection
- Need for appropriate antibiotic treatment
- Possible implementation of infection control measures
- For pregnant women: intrapartum antibiotic prophylaxis during delivery
Negative Result
A negative result suggests no detectable Group B Streptococcus antigens were found:
- No current evidence of Group B Streptococcus infection
- Continued monitoring may still be recommended based on clinical symptoms
- For pregnant women: reduced risk of transmitting GBS to newborn
Indeterminate Result
In rare cases, results may be unclear and require:
- Repeat testing with a new sample
- Additional diagnostic methods
- Clinical correlation with symptoms and physical examination
Test Pricing and Availability
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Streptococcus Group B Antigen Detection Test | $26 USD | $28 USD |
Nationwide Testing Availability
GGC DNA provides comprehensive Streptococcus Group B Antigen Detection testing services across the United States. Our state-of-the-art laboratories and collection centers are conveniently located in major metropolitan areas including:
- New York City and surrounding areas
- Los Angeles and Southern California
- Chicago and Illinois region
- Houston and Texas locations
- Phoenix and Arizona facilities
- Philadelphia and Pennsylvania centers
- And many additional locations nationwide
With daily turnaround times and no special preparation required, getting tested has never been more convenient. Our experienced healthcare professionals ensure comfortable sample collection and accurate result reporting.
Take Action for Your Health Today
Don’t wait to address potential Group B Streptococcus concerns. Early detection through the Streptococcus Group B Antigen Detection Test can prevent serious complications and guide effective treatment. Our affordable $26 pricing makes quality healthcare accessible to everyone.
Book your test now by calling +1(267) 388-9828 or visiting your nearest GGC DNA location. Our friendly staff is ready to assist you with scheduling, answer your questions, and provide the exceptional care you deserve.
Remember: Early detection saves lives. Trust GGC DNA for accurate, reliable Streptococcus Group B Antigen Detection testing with rapid results and professional service.
